This inventor holds 1 USPTO granted patent. Top assignees: Kawasaki Gakuen Educational Foundation, Sysmex Corporation, The University of Tokyo. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023
Title: Hironori Shimosaka: Innovator in Medical Prediction Methods
Introduction
Hironori Shimosaka is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical technology, particularly in predicting health conditions through innovative methods. His work has the potential to impact patient care and treatment outcomes.
Latest Patents
Hironori Shimosaka holds a patent for a method that assists in predicting the onset of cerebral infarction. This method involves analyzing the number of red blood cells in a blood sample collected from a subject. The process includes calculating an exponent value based on two different measurement methods, comparing this value with a reference range, and suggesting the likelihood of cerebral infarction if the value falls outside the range. This innovative approach aims to enhance early detection and intervention for patients at risk.
Career Highlights
Throughout his career, Hironori Shimosaka has worked with esteemed organizations such as the Kawasaki Gakuen Educational Foundation and Sysmex Corporation. His experience in these institutions has allowed him to develop and refine his innovative methods in medical prediction.
Collaborations
Hironori has collaborated with notable colleagues, including Akiko Masuda and Yutaka Yatomi. Their combined expertise has contributed to the advancement of medical technologies and research.
Conclusion
Hironori Shimosaka's work exemplifies the intersection of innovation and healthcare. His patented methods for predicting cerebral infarction demonstrate the potential for technology to improve patient outcomes. His contributions to the field are invaluable and highlight the importance of continued research and development in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile